Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells

Marked for death: targeting epigenetic changes in cancer

(2017) Sophia Xiao Pfister et al.   NATURE REVIEWS DRUG DISCOVERY

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.

(2015) Sevin Turcan et al.   Oncotarget

Epigenetic targeting in pancreatic cancer

(2014) Jasmijn G.M. van Kampen et al.   CANCER TREATMENT REVIEWS

Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling

(2014) Katia Nones et al.   INTERNATIONAL JOURNAL OF CANCER

Pancreatic Adenocarcinoma

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Somatostatin Receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer

(2013) J Zhao et al.   BRITISH JOURNAL OF CANCER

Effect of inhibition of MEK pathway on 5-aza-deoxycytidine-suppressed pancreatic cancer cell proliferation

(2013) X. Wang et al.   GENETICS AND MOLECULAR RESEARCH

miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells

(2013) Luc Gailhouste et al.   HEPATOLOGY

Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression

(2013) Jun Gao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The future of epigenetic therapy in solid tumours—lessons from the past

(2013) Nilofer Azad et al.   Nature Reviews Clinical Oncology

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pancreatic Ductal Adenocarcinoma

(2012) Ioannis T. Konstantinidis et al.   ANNALS OF SURGERY

Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells

(2012) Hsing-Chen Tsai et al.   CANCER CELL

Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma

(2012) R. Shakya et al.   CANCER RESEARCH

Cancer Epigenetics: From Mechanism to Therapy

(2012) Mark A. Dawson et al.   CELL

CpG islands and the regulation of transcription

(2011) A. M. Deaton et al.   GENES & DEVELOPMENT

Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo

(2011) Oscar Alcazar et al.   INTERNATIONAL JOURNAL OF CANCER

Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer

(2011) R. A. Juergens et al.   Cancer Discovery

Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy

(2010) Kjell E. Öberg et al.   GASTROENTEROLOGY

5′-AZA induces Ngn3 expression and endocrine differentiation in the PANC-1 human ductal cell line

(2009) Bruno Lefebvre et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

(2009) Pierre Fenaux et al.   LANCET ONCOLOGY

Identification of an Upstream Promoter of the Human Somatostatin Receptor, hSSTR2, Which Is Controlled by Epigenetic Modifications

(2008) Jérôme Torrisani et al.   ENDOCRINOLOGY

Antitumor effects of somatostatin

(2008) Stéphane Pyronnet et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Epigenetics in Cancer

(2008) Manel Esteller   NEW ENGLAND JOURNAL OF MEDICINE